CST3 and coronary artery disorder: Furthermore, a meta-analysis revealed that serum cystatin C is independently associated with adverse vascular outcomes in participants with suspected or established coronary artery disease in terms of all-cause and cardiovascular mortalities, independent of creatinine-based eGFR [24].